These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
375 related items for PubMed ID: 28165371
1. Protection against Shiga Toxins. Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K. Toxins (Basel); 2017 Feb 03; 9(2):. PubMed ID: 28165371 [Abstract] [Full Text] [Related]
2. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Liu Y, Tian S, Thaker H, Dong M. Toxins (Basel); 2021 Mar 18; 13(3):. PubMed ID: 33803852 [Abstract] [Full Text] [Related]
3. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Müthing J, Schweppe CH, Karch H, Friedrich AW. Thromb Haemost; 2009 Feb 18; 101(2):252-64. PubMed ID: 19190807 [Abstract] [Full Text] [Related]
9. Shiga toxins: from structure and mechanism to applications. Chan YS, Ng TB. Appl Microbiol Biotechnol; 2016 Feb 18; 100(4):1597-1610. PubMed ID: 26685676 [Abstract] [Full Text] [Related]
10. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections. Watanabe M, Matsuoka K, Kita E, Igai K, Higashi N, Miyagawa A, Watanabe T, Yanoshita R, Samejima Y, Terunuma D, Natori Y, Nishikawa K. J Infect Dis; 2004 Feb 01; 189(3):360-8. PubMed ID: 14745692 [Abstract] [Full Text] [Related]
11. Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells. Lee MS, Kim MH, Tesh VL. J Microbiol; 2013 Dec 01; 51(6):724-30. PubMed ID: 24385347 [Abstract] [Full Text] [Related]
12. Shiga toxin--an expanding role in the pathogenesis of infectious diseases. Cantey JR. J Infect Dis; 1985 May 01; 151(5):766-71. PubMed ID: 3886803 [No Abstract] [Full Text] [Related]
13. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. O'Brien AD, Tesh VL, Donohue-Rolfe A, Jackson MP, Olsnes S, Sandvig K, Lindberg AA, Keusch GT. Curr Top Microbiol Immunol; 1992 May 01; 180():65-94. PubMed ID: 1324134 [No Abstract] [Full Text] [Related]
14. Shiga toxins. Bergan J, Dyve Lingelem AB, Simm R, Skotland T, Sandvig K. Toxicon; 2012 Nov 01; 60(6):1085-107. PubMed ID: 22960449 [Abstract] [Full Text] [Related]
15. The ether lipid precursor hexadecylglycerol protects against Shiga toxins. Bergan J, Skotland T, Lingelem AB, Simm R, Spilsberg B, Lindbäck T, Sylvänne T, Simolin H, Ekroos K, Sandvig K. Cell Mol Life Sci; 2014 Nov 01; 71(21):4285-300. PubMed ID: 24740796 [Abstract] [Full Text] [Related]
16. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Infect Immun; 1993 Sep 01; 61(9):3886-91. PubMed ID: 8359910 [Abstract] [Full Text] [Related]
17. Shiga toxin and its use in targeted cancer therapy and imaging. Engedal N, Skotland T, Torgersen ML, Sandvig K. Microb Biotechnol; 2011 Jan 01; 4(1):32-46. PubMed ID: 21255370 [Abstract] [Full Text] [Related]